Tuesday, March 25, 2008 1:24:39 PM
"The shareholders of the Company will experience dilution as a result of the arrangement, up to 20 million additional shares of the Company's common stock. Mr. Janes will have the same number of shares of common stock in the Company as he had before the arrangement, but will be diluted to the extent that up to an additional 20 million shares of the Company's common stock are issued and outstanding as a result of the private placement. There is no assurance as to the amount or timing of any sales or purchases of shares that may be made under the arrangement, if any."
My perception was that it would be a gradual dilution in order to minimize the effects of applying 20M shares at once. I also thought that if FDA clearance were to come sooner, a rise in pps would benefit I3 by Dean selling shares at a higher rate, thus, more working capital. (?)
FEATURED ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • Jul 30, 2024 8:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • BLOZF • Jul 29, 2024 9:07 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM